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Dear Editor,
Alvarez, Urbina, and Tejada [1] comment on the im-
portance of considering chronic hepatitis C patients with 
cognitive impairment in the evaluation of health-related 
quality of life (HRQoL) [2], bearing in mind that this is a 
usual comorbidity in this population. They argue that in 
patients with chronic disease and low cognitive status, the 
caregivers should be a valuable source of information of 
their quality of life, as demonstrated by studies with neu-
rodegenerative disorders. They also propose the develop-
ment of specific instruments for assessing quality of life 
in patients with both chronic diseases and cognitive im-
pairment. 
We appreciate the contribution of Alvarez, Urbina, 
and Tejada [1] and agree on the relevance of evaluating 
quality of life in chronic hepatitis C patients regardless of 
the severity of extrahepatic manifestations. Recent evi-
dence suggests that one third of patients with chronic 
hepatitis C virus (HCV) can experience cognitive impair-
ment even in the absence of cirrhosis, although greater 
fibrosis correlates significantly with poorer cognitive 
functioning [3, 4]. Attention, concentration, working 
memory processes, and mental flexibility are the most 
frequently affected cognitive abilities early in the course 
of disease [4, 5]. These impairments are reported to affect 
quality of life and performance in professional and per-
sonal settings [4]. 
In our study, we considered cognitive impairment as 
an exclusion criteria if the patient demonstrated very se-
vere limitations that precluded a reliable understanding 
of the questions, including extremely low literacy level or 
illiteracy. We believe that this selection did not imply a 
low representability of this population, because the most 
frequently reported cognitive impairments, especially in 
the early stage of disease, are executive functions that do 
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not tend to compromise self-awareness of health state. 
Also, most patients readily self-completed the questions, 
and the patients with limitations were supported by our 
trained interviewer to confirm full completion of ques-
tionnaires. We also followed the methodology proposed 
by the authors of the disease-specific instrument used in 
our study, the Chronic Liver Disease Questionnaire 
(CLDQ), developed by Younossi et al. [6]. This instru-
ment is useful in all etiologies of liver disease at any sever-
ity stage [7] and appears to provide a valuable measure of 
HRQoL in chronic liver disease across diverse cultures 
[7]. In developing the instrument, the authors excluded 
patients with psychiatric comorbidity and language or 
cognitive difficulties that prevented reliable completion 
of the questionnaire [6].
We also agree on the importance of valuing the contri-
bution of caregivers in the evaluation of quality of life in 
chronic HCV patients with cognitive impairment. This 
could enable a more integrated approach to health care in 
this population. However, we should notice that in our 
study we used self-report instruments, for instance CLDQ 
domains (fatigue, activity, emotional function, abdomi-
nal symptoms, systemic symptoms, worry), including 
highly subjective items focused on emotional states and 
feelings [6], meaning that the interpretation given by the 
caregiver could induce some important bias. 
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